T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
+$2.23B |
| 2 |
Carvana
CVNA
|
+$1.65B |
| 3 |
Microsoft
MSFT
|
+$1.46B |
| 4 |
Affirm
AFRM
|
+$1.2B |
| 5 |
Walt Disney
DIS
|
+$1.18B |
Top Sells
| 1 |
Visa
V
|
+$2.51B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.93B |
| 4 |
Salesforce
CRM
|
+$1.88B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.52B |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.81% |
| 5 | Financials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Bloom Energy
BE
$15.7B
| $8.8M | ﹤0.01% |
470,083
-162,746
| -26% | -$3.05M |
|
1427
Protagonist Therapeutics
PTGX
$3.66B
| $8.71M | ﹤0.01% |
491,641
-494,613
| -50% | -$8.76M |
|
1428
Quince Therapeutics
QNCX
$85.9M
| $8.67M | ﹤0.01% |
94,554
+55,154
| +140% | +$5.06M |
|
|
NUAN
1429
DELISTED
Nuance Communications, Inc.
NUAN
| $8.62M | ﹤0.01% |
156,514
-13,301
| -8% | -$732K |
|
1430
Silicon Laboratories
SLAB
$4.39B
| $8.59M | ﹤0.01% |
61,301
-1,369
| -2% | -$192K |
|
1431
NNN REIT
NNN
$8.12B
| $8.59M | ﹤0.01% |
198,877
-91,119
| -31% | -$3.94M |
|
1432
Stoke Therapeutics
STOK
$1.29B
| $8.59M | ﹤0.01% |
337,582
-49,841
| -13% | -$1.27M |
|
|
VIRX
1433
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $8.57M | ﹤0.01% |
+1,068,812
| New | +$8.57M |
|
1434
Markel Group
MKL
$24.7B
| $8.55M | ﹤0.01% |
7,152
-582
| -8% | -$696K |
|
1435
Sylvamo
SLVM
$1.75B
| $8.49M | ﹤0.01% |
+259,741
| New | +$8.49M |
|
|
MTEM
1436
DELISTED
Molecular Templates, Inc.
MTEM
| $8.33M | ﹤0.01% |
82,730
-187
| -0.2% | -$18.8K |
|
|
OHPAU
1437
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $8.22M | ﹤0.01% |
831,549
| – | – |
|
|
CELL
1438
DELISTED
PhenomeX Inc. Common Stock
CELL
| $8.17M | ﹤0.01% |
417,730
-370,962
| -47% | -$7.26M |
|
1439
Jones Lang LaSalle
JLL
$14.8B
| $8.15M | ﹤0.01% |
32,843
-2,631
| -7% | -$653K |
|
|
NGM
1440
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $8.09M | ﹤0.01% |
384,716
-49,142
| -11% | -$1.03M |
|
1441
JetBlue
JBLU
$1.84B
| $8.09M | ﹤0.01% |
528,866
+336,176
| +174% | +$5.14M |
|
1442
eHealth
EHTH
$122M
| $8.07M | ﹤0.01% |
199,340
-34,050
| -15% | -$1.38M |
|
1443
Royal Gold
RGLD
$12.5B
| $8.07M | ﹤0.01% |
84,527
+541
| +0.6% | +$51.7K |
|
|
FRONU
1444
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $8.04M | ﹤0.01% |
814,927
| – | – |
|
1445
Orchestra BioMed
OBIO
$139M
| $7.99M | ﹤0.01% |
807,765
-2,373
| -0.3% | -$23.5K |
|
1446
Plug Power
PLUG
$1.76B
| $7.94M | ﹤0.01% |
310,733
+8,909
| +3% | +$228K |
|
1447
Berkshire Hathaway Class A
BRK.A
$1.06T
| $7.82M | ﹤0.01% |
19
| – | – |
|
1448
Vroom, Inc. Common Stock
VRM
$137M
| $7.79M | ﹤0.01% |
4,413
+4,332
| +5,348% | +$7.65M |
|
1449
Trinity Capital
TRIN
$1.13B
| $7.77M | ﹤0.01% |
482,773
+55,200
| +13% | +$888K |
|
|
CMRC
1450
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $7.73M | ﹤0.01% |
152,733
+142,764
| +1,432% | +$7.23M |
|